LIVER X RECEPTOR (LXR) activation may affect breast cancer risk through induction of tristetraprolin (TTP) in mamary epithelial cells

Tristetraprolin (TTP) down-regulation in mammary epithelial cells induces developmental delay and DUSP-6 phosphatase overexpression

E3 ubiquitin ligase HERC1 regulate breast cancer cells migration and invasion

Generation of a CRISPR/Cas9 EO771-tumor platform to study breast cancer cell – immune system interactions

DNA polymerase iota prevents unleashed DNA elongation to promote cell survival and genomic stability

GEF-H1 drives tumor formation, motility, invasion and metastasis in breast cancer

Exploring the role of hyaluronan and CD44 in resistance to ErbB-2-targeted therapies in breast cancer

A potential strategy to prevent drug resistance: Chromosome instability can be prevented with no changes in the induction of cell death after Chk1 depletion

Analysis of Akt molecular, subcellular and tumoral code as an explanatory and predictive tool for the effectiveness of therapies against breast cancer

Effect of 2’-nitroflavone on the expression of receptors associated with EGFR activity in breast cancer cells